Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Angela Crawley
Hepatitis C Direct Acting Antivirals and Ribavirin Modify Lipid but Not Glucose Parameters
Cells
Related publications
Treating Hepatitis B Virus/Hepatitis C Virus Coinfected Patients With Direct-Acting Hepatitis C Virus Antivirals Only Is Not Safe
Hepatology
Medicine
Hepatology
The Interplay Between Direct-Acting Antivirals and Hepatocellular Carcinoma in Chronic Hepatitis C
Hepatoma Research
Hepatitis C Related Hepatocellular Carcinoma in the Era of Direct-Acting Antivirals
Hepatoma Research
Direct‐Acting Antivirals in Hepatitis C Virus‐Associated Diffuse Large B‐cell Lymphomas
Oncologist
Cancer Research
Medicine
Oncology
Ribavirin Steady-State Plasma Level Is a Predictor of Sustained Virological Response in Hepatitis C-Infected Patients Treated With Direct-Acting Antivirals
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Editorial: Ribavirin Continues to Play a Role in Treatment With Direct-Acting Antivirals for Hepatitis C Virus-Infected Patients With Decompensated Cirrhosis
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Hepatitis B Reactivation in Chronic Hepatitis C Patients Treated With Interferon or Pan-Oral Direct-Acting Antivirals
Hepatology
Medicine
Hepatology
High Efficacy of Generic and Brand Direct Acting Antivirals in Treatment of Chronic Hepatitis C.
International Journal of Infectious Diseases
Medicine
Infectious Diseases
Microbiology
Direct-Acting Antivirals for the Treatment of Chronic Hepatitis C: Open Issues and Future Perspectives
The Scientific World Journal
Biochemistry
Medicine
Genetics
Molecular Biology
Environmental Science
